Henry Schein, Inc. (LON:0L3C)

London flag London · Delayed Price · Currency is GBP · Price in USD
81.95
+0.88 (1.08%)
At close: Feb 12, 2026
Market Cap7.05B -7.6%
Revenue (ttm)9.65B +3.5%
Net Income291.56M +24.5%
EPS2.36 +30.7%
Shares Outn/a
PE Ratio24.17
Forward PE15.58
Dividendn/a
Ex-Dividend Daten/a
Volume2
Average Volume190
Open82.20
Previous Close81.07
Day's Range81.95 - 82.45
52-Week Range60.80 - 82.45
Beta0.89
RSI62.91
Earnings DateFeb 24, 2026

About Henry Schein

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chair... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1932
Employees 25,000
Stock Exchange London Stock Exchange
Ticker Symbol 0L3C
Full Company Profile

Financial Performance

In 2024, Henry Schein's revenue was $12.67 billion, an increase of 2.71% compared to the previous year's $12.34 billion. Earnings were $390.00 million, a decrease of -6.25%.

Financial numbers in USD Financial Statements

News

Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement

Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement

2 months ago - GuruFocus

Barclays Initiates Coverage on HSIC with Overweight Rating | HSIC Stock News

Barclays Initiates Coverage on HSIC with Overweight Rating | HSIC Stock News

2 months ago - GuruFocus

Henry Schein Can Make Your Portfolio Smile

Henry Schein, Inc. is rated a Buy with solid growth, strong Q3 revenue & improved profitability across all segments. Learn more about HSIC stock here.

2 months ago - Seeking Alpha

Henry Schein Inc at Piper Sandler Healthcare Conference Transcript

Henry Schein Inc at Piper Sandler Healthcare Conference Transcript

2 months ago - GuruFocus

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

2 months ago - Seeking Alpha

HSIC Stock Benefits From Expanded Partnership With vVARDIS

Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.

2 months ago - Nasdaq

Henry Schein Expands Partnership with vVARDIS

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the dril...

2 months ago - Business Wire

HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch

HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting.

2 months ago - Nasdaq

Artisan Select Equity Fund Q3 2025 Portfolio Review

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung...

2 months ago - Seeking Alpha

Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting

AMERICAN FORK, Utah--(BUSINESS WIRE)--Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embe...

2 months ago - Business Wire

Peering Into Henry Schein Inc's Recent Short Interest

Henry Schein Inc's (NYSE: HSIC) short interest as a percent of float has fallen 4.94% since its last report. According to exchange reported data, there are now 8.38 million shares sold short , which ...

2 months ago - Benzinga

American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as p...

3 months ago - Seeking Alpha

Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript

Henry Schein, Inc. (HSIC) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM ESTCompany ParticipantsStanley Bergman - Executive Chairman...

3 months ago - Seeking Alpha

Worried About an AI Bubble? Here Are BofA's Top Stock Picks to Diversify Your Portfolio

If you're looking to diversify your stock portfolio away from AI, Bank of America has some suggestions.

3 months ago - Investopedia

Henry Schein to Participate in Upcoming Investor Conference in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Com...

3 months ago - Business Wire

Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too?

Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too?

3 months ago - The Motley Fool

KKR Moves To Take Japan's Forum Engineering Private

On Monday, KKR & Co. Inc. (NYSE: KKR) disclosed the plan to launch a tender offer for Japan-based company, Forum Engineering Inc. , through its subsidiary KJ003 Co., Ltd., owned by KKR-managed funds ...

3 months ago - Benzinga

JPMorgan Chase & Co. Reduces Stake in Henry Schein Inc.

JPMorgan Chase & Co. Reduces Stake in Henry Schein Inc.

3 months ago - GuruFocus

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said Chipotle Mexican Grill, Inc. (NYSE: CMG) is “too expensive.” Chipotle, on Oct. 29, reported quarterly earnings of 29 cents per share, in line ...

3 months ago - Benzinga

HSIC: JP Morgan Raises Price Target to $78. ...

HSIC: JP Morgan Raises Price Target to $78.00 While Maintaining "Overweight" Rating | HSIC Stock News

3 months ago - GuruFocus

Henry Schein (HSIC) Sees Price Target Raised to $79 by Barrington Research | HSIC Stock News

Henry Schein (HSIC) Sees Price Target Raised to $79 by Barrington Research | HSIC Stock News

3 months ago - GuruFocus

Morgan Stanley Maintains 'Underweight' Rating, Raises Price Target for HSIC | HSIC Stock News

Morgan Stanley Maintains 'Underweight' Rating, Raises Price Target for HSIC | HSIC Stock News

3 months ago - GuruFocus

HSIC November 2026 Options Begin Trading

Investors in Henry Schein Inc (Symbol: HSIC) saw new options become available today, for the November 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...

3 months ago - Nasdaq

HSIC Stock Gets Price Target Boost from Wells Fargo | HSIC Stock News

HSIC Stock Gets Price Target Boost from Wells Fargo | HSIC Stock News

3 months ago - GuruFocus